Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways.
暂无分享,去创建一个
S. Kushner | S. Boulton | M. Tijsterman | H. Kool | G. Smith | F. D. de Vrij | J. Schimmel | R. van Schendel | Juliette A Kamp | Núria Muñoz-Subirana | Sven van der Vlies